PLAC8L1 Inhibitors
PLAC8L1 inhibitors comprise a diverse array of chemical compounds that intricately modulate cellular signaling pathways to achieve a reduction in PLAC8L1 activity. These compounds include kinase inhibitors which directly interfere with kinase activities critical for PLAC8L1's functional role. By obstructing phosphorylation processes, these inhibitors halt the cascade of events necessary for PLAC8L1's proper function. Additionally, other inhibitors target pivotal signaling pathways such as PI3K/Akt and mTOR, which are integral to a host of cellular functions. The inhibition of these pathways has a downstream effect that reduces the activity of PLAC8L1, as it is regulated by the outputs of these pathways. Agents that inhibit signaling mediated by protein kinase C, p38 MAPK, MEK, and JNK also play a role in diminishing PLAC8L1 activity, as these kinases are central to signaling cascades that dictate PLAC8L1 function.
Moreover, inhibitors that affect calcium signaling pathways also serve to dampen PLAC8L1 activity. Specifically, compounds that antagonize calmodulin or chelate intracellular calcium disrupt the calmodulin-dependent and calcium-dependent processes that are vital to PLAC8L1's regulatory functions. Inhibitors targeting calcium pumps such as SERCA, or those that block the IP3 receptor, alter calcium signaling, leading to reduced PLAC8L1 activity through the disruption of calcium-dependent signaling mechanisms.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Staurosporine | 62996-74-1 | sc-3510 sc-3510A sc-3510B | 100 µg 1 mg 5 mg | $82.00 $153.00 $396.00 | 113 | |
A potent kinase inhibitor that disrupts various signaling pathways including those regulated by PLAC8L1. By inhibiting kinases, this compound interferes with phosphorylation events essential for PLAC8L1's activity, leading to its functional inhibition. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
A PI3K inhibitor that prevents the activation of the PI3K/Akt signaling pathway. As PLAC8L1 might be regulated downstream of PI3K, inhibition of this kinase can lead to decreased PLAC8L1 activity. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
An mTOR inhibitor that impedes the mTOR signaling pathway. Given that PLAC8L1 functions could be associated with mTOR pathway outputs, its activity is likely decreased by this compound. | ||||||
Chelerythrine chloride | 3895-92-9 | sc-3547 sc-3547A | 5 mg 25 mg | $90.00 $317.00 | 17 | |
A PKC inhibitor that hampers protein kinase C (PKC)-mediated signaling events, potentially leading to reduced PLAC8L1 activity through downstream effects on signaling cascades. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
A p38 MAPK inhibitor that blocks the p38 MAPK pathway. Since this pathway can control various protein functions, inhibiting it can indirectly result in the decreased activity of PLAC8L1. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $40.00 $92.00 | 212 | |
An MEK inhibitor that disrupts the MAPK/ERK pathway. This pathway can have regulatory effects on a multitude of proteins, and its inhibition can indirectly reduce PLAC8L1 activity. | ||||||
U-0126 | 109511-58-2 | sc-222395 sc-222395A | 1 mg 5 mg | $64.00 $246.00 | 136 | |
An MEK inhibitor that inhibits the MAPK/ERK pathway and can therefore indirectly decrease PLAC8L1 activity through downstream signaling effects. | ||||||
SP600125 | 129-56-6 | sc-200635 sc-200635A | 10 mg 50 mg | $40.00 $150.00 | 257 | |
A JNK inhibitor that affects the JNK signaling pathway. JNK pathway modulation can regulate various proteins, with inhibition leading to a potential decrease in PLAC8L1 activity. | ||||||
W-7 | 61714-27-0 | sc-201501 sc-201501A sc-201501B | 50 mg 100 mg 1 g | $166.00 $306.00 $1675.00 | 18 | |
A calmodulin antagonist that disrupts calmodulin-dependent signaling pathways, which might be involved in the regulation of PLAC8L1, leading to its functional inhibition. | ||||||
BAPTA/AM | 126150-97-8 | sc-202488 sc-202488A | 25 mg 100 mg | $138.00 $458.00 | 61 | |
A calcium chelator that sequesters intracellular calcium and can inhibit calcium-dependent signaling pathways, potentially reducing PLAC8L1 activity. | ||||||